Learn More
With the continuing growth in the amount of genetic data, members of the bioinformatics community are developing a variety of data-mining applications to understand the data and discover meaningful information. These applications are important in defining the design and performance decisions of future high performance microprocessors. This paper presents a(More)
Tarantula is an aggressive floating point machine targeted at technical, scientific and bioinformatics workloads, originally planned as a follow-on candidate to the EV8 processor [6, 5]. Tarantula adds to the EV8 core a vector unit capable of 32 double-precision flops per cycle. The vector unit fetches data directly from a 16 MByte second level cache with a(More)
To investigate the therapeutic value and safety of the biweekly regimen of 5-fluorouracil (5-FU) and leucovorin (LV) plus irinotecan (CPT-11) in patients with previously untreated advanced gastric cancer (AGC). A total of 50 patients (M/F 35/15; median age = 65) with AGC, none of whom had received chemotherapy for advanced disease, were accrued in this(More)
Centralized monolithic processor designs, such as single core and shared bus structures, are not scaling, leading to multicore designs becoming the norm [1-3]. Research highlights the benefits of mesh networks connecting these cores. [4,5]. The TILE64™ processor [6] is a multicore SoC targeting the high-performance demands of a wide range of embedded(More)
The ideal computerized mammogram processing system still needs to be developed. In order to achieve maximum flexibility we suggest a modular scheme, dividing the processing sequence into functionally autonomous modules. This paper provides a general scheme for detection and/or automated recognition of microcalcifications. Some modules that perform ROI(More)
Epithelial ovarian carcinoma represents a prototypic example of neoplastic disease sharing at the same time good chemosensitivity as well as marked propensity to relapse. If in one hand the definition of almost clear-cut guidelines has been reached in the setting of first-line therapy (i.e., cytoreductive surgery followed by first-line chemotherapy), more(More)